Figure 1.

Complete response rate (A) and complete control rate (B) in the modified intention-to-treat population (n = 299) on a daily basis. (A): The risk difference between the two arms was 7.8% (90% confidence interval [CI], 1.4%–14.1%), and the value adjusted for gender was 6.8% (90% CI, 0.2%–13.3%). (B): The risk difference between the two arms was 9.8% (90% CI, 1.9%–17.6%), and the value adjusted for gender was 7.1% (90% CI, −0.9%–15.2%) using the generalized estimating equation model.

Abbreviations: OAD, ondansetron, aprepitant, and dexamethasone; RAD: ramosetron, aprepitant, and dexamethasone.